Anchor Investment Management LLC lessened its stake in Crescent Capital BDC, Inc. (NASDAQ:CCAP – Free Report) by 6.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 16,909 shares of the company’s stock after selling 1,070 shares during the period. Anchor Investment Management LLC’s holdings in Crescent Capital BDC were worth $289,000 as of its most recent SEC filing.
Other institutional investors have also recently bought and sold shares of the company. Ameriprise Financial Inc. raised its position in Crescent Capital BDC by 7.2% in the 4th quarter. Ameriprise Financial Inc. now owns 70,135 shares of the company’s stock worth $1,348,000 after purchasing an additional 4,706 shares during the last quarter. Pettinga Financial Advisors LLC raised its position in Crescent Capital BDC by 57.7% in the 4th quarter. Pettinga Financial Advisors LLC now owns 45,767 shares of the company’s stock worth $880,000 after purchasing an additional 16,750 shares during the last quarter. Kovitz Investment Group Partners LLC raised its position in Crescent Capital BDC by 14.4% in the 1st quarter. Kovitz Investment Group Partners LLC now owns 202,873 shares of the company’s stock worth $3,473,000 after purchasing an additional 25,528 shares during the last quarter. Millennium Management LLC raised its position in Crescent Capital BDC by 23.2% in the 4th quarter. Millennium Management LLC now owns 87,134 shares of the company’s stock worth $1,675,000 after purchasing an additional 16,402 shares during the last quarter. Finally, Cetera Investment Advisers raised its position in Crescent Capital BDC by 12.9% in the 4th quarter. Cetera Investment Advisers now owns 18,712 shares of the company’s stock worth $360,000 after purchasing an additional 2,141 shares during the last quarter. Institutional investors own 49.46% of the company’s stock.
Insider Activity
In other news, Director Raymond Barrios purchased 3,245 shares of the firm’s stock in a transaction dated Monday, August 25th. The stock was bought at an average price of $15.63 per share, with a total value of $50,719.35. Following the acquisition, the director directly owned 19,177 shares of the company’s stock, valued at approximately $299,736.51. This represents a 20.37% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.14% of the stock is owned by company insiders.
Analyst Ratings Changes
Check Out Our Latest Report on CCAP
Crescent Capital BDC Trading Down 1.4%
Shares of CCAP stock opened at $15.59 on Thursday. Crescent Capital BDC, Inc. has a 12-month low of $13.54 and a 12-month high of $20.19. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a fifty day moving average of $14.89 and a 200-day moving average of $15.57.
Crescent Capital BDC (NASDAQ:CCAP – Get Free Report) last announced its quarterly earnings results on Wednesday, August 13th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.46. Crescent Capital BDC had a net margin of 24.12% and a return on equity of 10.55%. The company had revenue of $42.99 million during the quarter, compared to analyst estimates of $42.52 million. Sell-side analysts predict that Crescent Capital BDC, Inc. will post 2.09 EPS for the current fiscal year.
Crescent Capital BDC Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Tuesday, September 30th will be issued a $0.42 dividend. The ex-dividend date of this dividend is Tuesday, September 30th. This represents a $1.68 annualized dividend and a dividend yield of 10.8%. Crescent Capital BDC’s payout ratio is 140.00%.
About Crescent Capital BDC
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Stories
- Five stocks we like better than Crescent Capital BDC
- What is an Earnings Surprise?
- Part of the Club: Robinhood & AppLovin Soar on S&P 500 Inclusion
- Top Biotech Stocks: Exploring Innovation Opportunities
- Despite Pullback, Rocket Lab Still Looks Primed for a Breakout
- Most active stocks: Dollar volume vs share volume
- Analyst Upgrades Strengthen Microsoft’s Long-Term Outlook
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.